Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit?

Abstract

ANTIPLATELET THERAPY HAS A PROMINENT ROLE IN THE treatment of a broad range of cardiovascular diseases, and data supporting the role of aspirin in secondary prevention are robust. As monotherapy, the thienopyridine clopidogrel has also been shown to have modestly superior efficacy compared with aspirin in secondary prevention for patients with recent… (More)
DOI: 10.1001/jama.2009.1249

Topics

Cite this paper

@article{Bhatt2009TailoringAT, title={Tailoring antiplatelet therapy based on pharmacogenomics: how well do the data fit?}, author={Deepak L Bhatt}, journal={JAMA}, year={2009}, volume={302 8}, pages={896-7} }